Please use this identifier to cite or link to this item:
|Title:||The gut microbiota as a modulator of innate immunity during melioidosis|
|Authors:||Lankelma, Jacqueline M.|
Weehuizen, Tassili A. F.
Scicluna, Brendon P.
Houtkooper, Riekelt H.
Roelofs, Joris J. T. H.
Vos, Alex F. de
Poll, Tom van der
Budding, Andries E.
Joost Wiersinga, W.
Bacteria -- Metabolism
Diseases -- Animal models
Gastrointestinal system -- Diseases
|Citation:||Lankelma, J. M., Birnie, E., Weehuizen, T. A., Scicluna, B. P., Belzer, C., Houtkooper, R. H., ... & Wiersinga, W. J. (2017). The gut microbiota as a modulator of innate immunity during melioidosis. PLoS Neglected Tropical Diseases, 11(4), e0005548.|
|Abstract:||Background: Melioidosis, caused by the Gram-negative bacterium Burkholderia pseudomallei, is an emerging cause of pneumonia-derived sepsis in the tropics. The gut microbiota supports local mucosal immunity and is increasingly recognized as a protective mediator in host defenses against systemic infection. Here, we aimed to characterize the composition and function of the intestinal microbiota during experimental melioidosis.|
Methodology/principal findings: C57BL/6 mice were infected intranasally with B. pseudomallei and sacrificed at different time points to assess bacterial loads and inflammation. In selected experiments, the gut microbiota was disrupted with broad-spectrum antibiotics prior to inoculation. Fecal bacterial composition was analyzed by means of IS-pro, a 16S-23S interspacer region-based profiling method. A marked shift in fecal bacterial composition was seen in all mice during systemic B. pseudomallei infection with a strong increase in Proteobacteria and decrease in Actinobacteria, with an increase in bacterial diversity. We found enhanced early dissemination of B. pseudomallei and systemic inflammation during experimental melioidosis in microbiota-disrupted mice compared with controls. Whole-genome transcriptional profiling of the lung identified several genes that were differentially expressed between mice with a normal or disrupted intestinal microbiota. Genes involved in acute phase signaling, including macrophage-related signaling pathways were significantly elevated in microbiota disrupted mice. Compared with controls, alveolar macrophages derived from antibiotic pretreated mice showed a diminished capacity to phagocytose B. pseudomallei. This might in part explain the observed protective effect of the gut microbiota in the host defense against pneumonia-derived melioidosis.
Conclusions/significance: Taken together, these data identify the gut microbiota as a potential modulator of innate immunity during B. pseudomallei infection.
|Appears in Collections:||Scholarly Works - FacHScABS|
Files in This Item:
|The_gut_microbiota_as_a_modulator_of_innate_immunity_during_melioidosis.pdf||9.44 MB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.